Radiation-induced cognitive dysfunction favorably impacted by fetal stem cell transplantation
8/26/2013
Patients receiving cranial irradiation treatment for brain cancer may find the treatment life-saving, but often suffer progressive and debilitating cognitive detriments, including spatial learning and memory deficits. The cognitive deficits are a contributing factor to the often significant adverse impacts on the surviving patients' quality of life after radiation therapy...
Future screening test could detect ovarian cancer earlier
8/26/2013
Scientists have developed a new screening strategy for ovarian cancer, which could detect the disease in its early stages, according to a study published in the journal Cancer...
Decitabine for blood cancers may stop spread of breast cancer cells
8/26/2013
A drug used to treat blood cancers may also stop the spread of invasive breast cancer, researchers at Mayo Clinic in Florida have discovered...
Red hair and melanoma may have genetic link
8/23/2013
A mutation in a gene called MC1R gives redheads their hair color and fair skin. Now a new US study suggests this same mutation triggers a cancer-causing signalling pathway when redheads are exposed to ultraviolet (UV) radiation. This may explain, the researchers say, why redheaded people have a higher risk for melanoma, the rarest but deadliest form of skin cancer...
Phase II clinical study with melflufen in the treatment of multiple myeloma patients initiated
8/23/2013
Oncopeptides AB, a company working to enhance oncology therapies, today announced that the first patient has been dosed as part of a Phase II study in multiple myeloma patients with its drug candidate melflufen (previously called J1)...
Leukaemia drug could help treat breast cancer
8/23/2013
A drug currently used to treat leukaemia might also help prevent breast cancer from spreading to other parts of the body, suggests an animal study in the open-access journal Breast Cancer Research. The discovery could also pave the way for improved early diagnostics...
Two oral targeted drugs approved for metastatic kidney cancer worked equally well, but one proved superior in tolerability, according to results of a large international clinical trial led by researchers at Dana-Farber Cancer Institute...
Acid, not bubbles, responsible for distinctive 'bite' of carbonated beverages
8/23/2013
New research from the Monell Center reveals that bubbles are not necessary to experience the unique 'bite' of carbonated beverages. Bubbles do, however, enhance carbonation's bite through the light feel of the bubbles picked up by our sense of touch. The refreshing bite of carbonation is an integral part of beverages consumed around the globe...
Clot-dissolving drug administered to greater variety of patients, still not fully utilized
8/23/2013
Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011...
Lymphoma treatment aided by 25% cut in normal calories - animal study
8/22/2013
A new experiment in mice suggests that a diet with below-normal calories could help the effectiveness of drug cancer treatment. The team, led by Jean-Ehrland Ricci of the French Institute for Health and Medical Research in France, put mice who had developed lymphoma into two separate groups: those who ate a diet with caloric intake 25% lower than normal, and those who ate a regular diet...